Biosimilars

Filter

Current filters:

None

Popular Filters

1 to 25 of 116 results

Polish and European generics groups view opportunities for biosimilars

29-10-2014

The European Biosimilars Group – a sector group of the European Generic medicines Association, together…

BiosimilarsEastern EuropeGenericsMarkets & MarketingPolandPricingRegulation

Discussion launched about the future of biosimilars in Italy

Discussion launched about the future of biosimilars in Italy

23-10-2014

Results from a survey of 470 European physicians conducted by the Alliance for Safe Biologic Medicines…

BiosimilarBiosimilarsBiotechnologyItalyRegulation

Russia’s Generium to establish MabThera analogue production

16-10-2014

Generium Group of Companies, one of Russia’s largest producers of innovative drugs, has commissioned…

BiosimilarsBiotechnologyGeneriumMabTheraOncologyProductionRocheRussia

Rheumatologists welcome novel biologics for systemic lupus erythematosus, survey finds

Rheumatologists welcome novel biologics for systemic lupus erythematosus, survey finds

16-10-2014

Rheumatologists would welcome novel biologics for the treatment of systemic lupus erythematosus (SLE),…

BenlystaBiosimilarsGlaxoSmithKlineHealthcareNeurologicalPharmaceuticalResearchUSA

Biosimilars one of the most promising segments of European pharma industry, says KuickResearch

Biosimilars one of the most promising segments of European pharma industry, says KuickResearch

09-10-2014

Biosimilars are one of the most promising segments of the European pharma industry, according to a report…

BiosimilarsEuropeLantusMarkets & MarketingPharmacology

France generics association GEMME to hold symposium in support of domestic biosimilar production

France generics association GEMME to hold symposium in support of domestic biosimilar production

06-10-2014

The French generics-maker association, GEMME, is to hold the first symposium on the challenges and opportunities…

BiosimilarsFranceMarkets & MarketingPharmaceutical sciencesPharmacology

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

Clear conditions for biosimilars the best way to boost patient safety says Danish Pharmaceutical Association

06-10-2014

When treating patients, patient safety is crucial. Regardless of whether this concerns biological, biosimilar…

BiosimilarsBiotechnologyDenmarkPharmacologyRegulation

Biosimilars set to revolutionize global drug development industry, says report

Biosimilars set to revolutionize global drug development industry, says report

30-09-2014

Intellectual Property and Science business of Thomson Reuters today announced the release of Biosimilars:…

BiosimilarsBiotechnologyGlobalMarkets & MarketingResearch

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy

18-09-2014

Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

EuropaBio calls for EMA action on labeling of biosimilars

18-09-2014

EuropaBio has published a statement giving the perspective of the health care biotechnology industry…

BiosimilarsBiotechnologyEuropeRegulation

Opportunity for emerging agents in Crohn’s disease, report finds

Opportunity for emerging agents in Crohn’s disease, report finds

18-09-2014

New research from Decision Resources Group has found that only a small proportion of patients with Crohn's…

Anti-Arthritics/RheumaticsBiosimilarsEntyvioHumiraPharmaceuticalRemicadeResearchStelaraUSAXeljanz

Biosimilars market could make vast cost savings - but only if it is sustainable: report

Biosimilars market could make vast cost savings - but only if it is sustainable: report

15-09-2014

Biosimilars stand to represent a major opportunity for cost saving across Europe as long as it becomes…

BiosimilarBiosimilarsDrugsEuropeEuropean Biosimilars GroupMarkets & Marketing

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Green Cross Neulapeg biosimilar approved in South Korea

28-08-2014

South Korea’s Green Cross says that the country’s Ministry of Food and Drug Safety has granted marketing…

AmgenAsia-PacificBiosimilarsBiotechnologyGreen CrossNeulapegNeulastaOncologyRegulation

Brazilian antitrust agency approves Bionovis and Merck's partnership deal

Brazilian antitrust agency approves Bionovis and Merck's partnership deal

28-08-2014

The General Superintendent of the Brazilian Antitrust Agency (CADE) approved the agreement between the…

BionovisBiosimilarsBrazilLicensingMerck KGaAPharmaceuticalResearch

China monoclonal antibody research forecast to increase

China monoclonal antibody research forecast to increase

28-08-2014

Several Chinese large-scale pharmaceutical enterprises have devoted themselves to research and development…

BiosimilarsBiotechnologyChinaHengrui MedicineMarkets & MarketingQilu PharmResearchShanghai Pharmaceuticals

1 to 25 of 116 results

Parexel

Parexel

Back to top